Germany-based company Innoplexus AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies in early-stage drug discovery. The company also has its offices in...
Read More
Innoplexus will now be a part of NVIDIA Inception Program. A program that is designed to nurture dedicated and exceptional startups who are revolutionizing industries with advances in AI and...
Read More
Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply of high-quality data because, without the right...
Read More
Innoplexus aims to democratize drug development with launch of new iPlexus Eschborn, Germany: Innoplexus AG announced today a groundbreaking update coming soon to their iPlexus platform that will leverage the power...
Read More
2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a challenging question. That is where Artificial Intelligence solutions and blockchain...
Read More
It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to corruption charges, the issues that American pharmaceutical companies face today...
Read More
